Most teaching treats interactions as hazards, but examiners also ask about interactions that are used on purpose and about precipitants that are not medicines at all. Every example below is a mechanism example only.
Interactions used deliberately. Some medicines are combined so that one changes the handling of the other. In antiviral treatment, ritonavir or cobicistat, both strong CYP3A inhibitors, are given as pharmacokinetic enhancers ("boosters") so that a co-administered antiviral reaches higher and longer-lasting levels. A historical example is probenecid, which competes for renal tubular secretion and so slows the excretion of penicillin. Pharmacodynamic antagonism is also used deliberately when an antidote such as naloxone displaces an opioid from its receptors.
Drug-food interactions. Food can act as the precipitant in several ways:
| Food or drink | Mechanism | Teaching example |
|---|
| Grapefruit juice | Furanocoumarins inhibit intestinal CYP3A4 | Higher levels of felodipine and some statins |
| Milk, antacids and mineral supplements | Calcium, magnesium, iron or aluminium ions chelate the drug in the gut | Reduced absorption of tetracyclines and fluoroquinolones |
| Tyramine-rich foods such as aged cheese | Monoamine oxidase inhibitors stop tyramine being broken down in the gut wall and liver | Hypertensive reaction, the classic "cheese reaction" |
| Leafy green vegetables | Vitamin K opposes the anticoagulant action of warfarin | Pharmacodynamic antagonism |
Drug-disease interactions. Here a medical condition, not another drug, changes the response. Non-selective beta-blockers can provoke bronchospasm in asthma, and NSAIDs can cause fluid retention that worsens heart failure and reduce kidney blood flow in renal impairment. In an essay, name the condition, the pharmacological reason and the outcome, exactly as you would for a drug pair.
Smoking. Polycyclic aromatic hydrocarbons in tobacco smoke, not nicotine, induce CYP1A2. Levels of CYP1A2 substrates such as theophylline, clozapine and caffeine are therefore lower in smokers and can rise when someone stops smoking. Nicotine replacement products do not reverse this, because they contain no hydrocarbons, which is a frequent viva follow-up.
For a fuller professional summary of mechanisms, the NHS Specialist Pharmacy Service article Understanding drug interactions is a sound second source to read alongside your textbook.